SEARCH

SEARCH BY CITATION

References

  • Akrich, M. (1992) The description of technical objects. In Bijker, W. and Law, J. (eds) Shaping Technology/Building Society: Studies in Sociotechnical Change. Cambridge, MA: MIT Press.
  • Appelbe, G.E. (2005) From arsenic to thalidomide: a brief history of medicine safety. In Anderson, S.C. (ed.) Making Medicines: A Brief History of Pharmacy and Pharmaceuticals. London: Pharmaceutical Press.
  • Brown, N. and Michael, M. (2003) A sociology of expectations: retrospecting prospects and prospecting retrospects, Technology Analysis & Strategic Management, 15, 1, 318.
  • Clarke, A., Mamo, L. and Fosker, J. (eds) (2010) Biomedicalization: Technoscience, Health and Illness in the US. Durham, NC: Duke University Press.
  • Collins, H. (1975) The seven sexes: a study in the sociology of the phenomenon, or the replication of experiments in physics, Sociology, 9, 2, 20524.
  • Collins, H. (1985) Changing Order: Replication and Induction in Scientific Practice. Chicago, IL: University of Chicago Press.
  • Faulkner, A., Geesink, I., Kent, J. and FitzPatrick, D. (2003) Human tissue engineered products – drugs or devices?, British Medical Journal, 326, 115960.
  • Franklin, S. (2001) Culturing biology: cell lines for the new millennium, Health, 5, 3, 33554.
  • Gene Therapy Advisory Committee (GTAC) (2009) Interim UK Regulatory Route Map for Stem Cell Research and Manufacture. Available at http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_097284.pdf (date last consulted 20 October 2009).
  • Haddow, G., Bruce, A., Calvert, J., Harmona, S. and Marsdena, A. (2010) Not ‘human’ enough to be human but not ‘animal’ enough to be animal – the case of the HFEA, cybrids and xenotransplantation in the UK, New Genetics and Society, 29, 1, 317.
  • Hammond-Browning, N. and Stephens, N. (in press) Moving human embryonic stem cells internationally: near-future challenges for the UK Stem Cell Bank and American collaborators. In Priaulx, N. and Wrigley, A. (eds) Ethics, Law and Society, Vol 5. Farnham, Surrey: Ashgate Publishing.
  • Hutter, B.M. (2006) The Role of Non-State Actors in Regulation. Discussion Paper No. 37. London: London School of Economics and Political Science (LSE).
  • Jasanoff, S. (2005) Designs on Nature Princeton. Princeton, NJ: Princeton University Press.
  • Jordan, K. and Lynch, M. (1998) The dissemination, standardization and routinization of a molecular biological technique, Social Studies of Science, 28, 5/6, 773800.
  • Kent, J. (2008) The fetal tissue economy: from the abortion clinic to the stem cell laboratory, Social Science & Medicine, 67, 11, 174756.
  • Lewis, J. and Atkinson, P. (2011) The surveillance of cellular scientists’ practice, BioSocieties, 6, 4, 381400.
  • Martin, P., Brown, N. and Kraft, A. (2008) From bedside to bench? Communities of promise, translational research and the making of blood stem cells, Science as Culture, 17, 2941.
  • Medicines and Healthcare Products Regulatory Agency (MHRA) (2008) Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2007 – The ‘Orange Guide’. Available at http://www.mhra.gov.uk/Publications/Regulatoryguidance/Medicines/CON2030291 (date last consulted 29 October 2008).
  • Oudshoorn, N. and Pinch, T. (2003) How Users Matter: The Co-construction of Users and Technology. Cambridge, MA: MIT Press.
  • Pfeffer, N. (2009) How work reconfigures an unwanted pregnancy into ‘the right tool for the job’ in stem cell research, Sociology of Health and Illness, 31, 1, 98111.
  • Pfeffer, N. and Kent, J. (2007) Framing women, framing fetuses: how Britain regulates arrangements for the collection and use of aborted foetuses in stem cell research and therapies, BioSocieties, 2, 4, 42947.
  • Pinch, T. and Bijker, W. (1984) The social construction of facts and artefacts: or how the sociology of science and the sociology of technology might benefit each other, Social Studies of Science, 14, 399441.
  • Rothstein, H., Irwin, A., Yearley, S. and McCarthy, E. (1999) Regulatory science, Europeanisation and the control of agrochemicals, Science, Technology and Human Values, 27, 24164.
  • Stacey, G. (2004) First Report from the UK Stem Cell Bank. Potters Bar: National Institute for Biological Standards and Control.
  • Stacey, G. and Stephens, N. (2012) Social science in a stem cell laboratory: what happened when social and life sciences met, Regenerative Medicine, 7, 11726.
  • Stephens, N., Atkinson, P. and Glasner, P. (2008a) The UK Stem Cell Bank: securing the past, validating the present, protecting the future, Science as Culture, 17, 4356.
  • Stephens, N., Atkinson, P. and Glasner, P. (2008b) The UK Stem Cell Bank as performative architecture, New Genetics and Society, 27, 8799.
  • Stephens, N., Atkinson, P. and Glasner, P. (2011a) Documenting the doable and doing the documented: bridging strategies at the UK Stem Cell Bank, Social Studies of Science, 41, 791813.
  • Stephens, N., Atkinson, P. and Glasner, P. (2011b) Internationaliser des standards, metter en banquet avec confiance: la mise en banquet de cellules souches s trois systèmes nationaux, Revue d’Anthropologie des Connaissances, 5, 26086.
  • Wainwright, S.P. (2005) Can stem cells cure Parkinson’s disease? Embryonic steps toward a regenerative brain medicine, British Journal of Neuroscience Nursing, 1, 616.
  • Wainwright, S.P., Williams, C., Michael, M., Farsides, B. and Cribb, A. (2006) From bench to bedside? Biomedical scientists’ expectations of stem cell science as a future therapy for diabetes, Social Science & Medicine, 63, 205264.
  • Waldby, C. (2002) Stem cells, tissue cultures and the production of biovalue, Health, 6, 3, 30523.
  • Winch, P. (1958) The Idea of a Social Science and its Relation to Philosophy. London: Routledge & Kegan Paul.
  • Wittgenstein, L. (1953) Philosophical Investigations. Editors: Anscombe, G.E.M. (trans.) and Rhees, R. Oxford: Blackwell.
  • Zarzeczny, A., Scott, C., Hyun, I., Bennett, J., et al. (2009) iPS cells: mapping the policy issues, Cell, 139, 10327.